Durability of Active Surveillance for Localized Renal Masses: 3-year Outcomes in the Michigan Urological Surgery Improvement Collaborative
In Michigan, most patients diagnosed with localized renal masses of <4 cm and some with tumors up to 7 cm in size elect active surveillance (AS), with a 13% cumulative incidence of undergoing intervention within 3 yr of detection. At 3 yr after initiating AS, the cohort had 90% overall survival and >99% cancer-specific survival, indicating that AS is a safe and durable strategy.
Authors
- Monica VanTil
- Sabrina L. Noyes (ORCID: https://orcid.org/0000-0002-0263-0650)
- Craig Rogers (ORCID: https://orcid.org/0000-0002-7781-6644)
- Brian R. Lane (ORCID: https://orcid.org/0000-0003-1084-1519)
- Alice Semerjian (ORCID: https://orcid.org/0000-0002-8031-993X)
- Khurshid R. Ghani (ORCID: https://orcid.org/0000-0002-6089-0733)
- Samantha Wilder
- Mahin Mirza
- Brian Seifman
- Mackenzie Gammons
- Yuzhi Wang (ORCID: https://orcid.org/0000-0003-3552-1589)
- Mohammad Jafri
Institutions
- Grand Rapids Community College (US)
- Van Andel Institute (US)
- University of Michigan (US)
- Michigan Institute of Urology (US)
- Comprehensive Urology (US)
- Michigan State University (US)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1016/j.euros.2025.02.005
- Citations
- 3
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56